LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 16.00 | 771.67 | 1582 | 1585 | 0.9978 | 0.9958 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 16.00 | 771.67 | 1844 | 1585 | 1.1630 | 1.3130 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 16.00 | 771.67 | 1698 | 1585 | 1.0710 | 1.1364 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 16.00 | 771.67 | 1391 | 1585 | 0.8773 | 0.7633 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.22 | 771.67 | 1744 | 1741 | 1.0015 | 1.0026 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.22 | 771.67 | 2042 | 1741 | 1.1726 | 1.2905 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.22 | 771.67 | 1845 | 1741 | 1.0595 | 1.1009 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.22 | 771.67 | 1575 | 1741 | 0.9045 | 0.8361 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.44 | 771.67 | 1898 | 1910 | 0.9933 | 0.9897 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.44 | 771.67 | 2246 | 1910 | 1.1754 | 1.2630 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.44 | 771.67 | 2003 | 1910 | 1.0482 | 1.0733 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.44 | 771.67 | 1697 | 1910 | 0.8881 | 0.8265 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.66 | 771.67 | 2071 | 2141 | 0.9671 | 0.9551 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.66 | 771.67 | 2506 | 2141 | 1.1702 | 1.2253 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.66 | 771.67 | 2200 | 2141 | 1.0273 | 1.0369 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.66 | 771.67 | 1895 | 2141 | 0.8849 | 0.8406 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.89 | 771.67 | 2323 | 2397 | 0.9688 | 0.9617 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.89 | 771.67 | 2775 | 2397 | 1.1573 | 1.1869 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.89 | 771.67 | 2380 | 2397 | 0.9926 | 0.9909 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.89 | 771.67 | 2163 | 2397 | 0.9021 | 0.8779 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 27.11 | 771.67 | 2650 | 2675 | 0.9906 | 0.9895 | MN20160304_L01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 27.11 | 771.67 | 3062 | 2675 | 1.1446 | 1.1564 | MN20160304_L01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 27.11 | 771.67 | 2606 | 2675 | 0.9742 | 0.9710 | MN20160304_L01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 27.11 | 771.67 | 2393 | 2675 | 0.8945 | 0.8795 | MN20160304_L01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 29.33 | 771.67 | 2959 | 2939 | 1.0067 | 1.0069 | MN20160304_L01 | G22 |